Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Survey Highlights High Out-of-pocket Costs for RA Care

Richard Quinn  |  October 25, 2013

The “RA in America 2013″ survey estimates out-of-pocket cost for RA treatment at  $1,000 to $5,000 per year. (posted Oct. 25)

Telomere Length Provides Insights into Cartilage Aging and Repair

Lara C. Pullen, PhD  |  October 8, 2013

Chondrocyte telomere length might play a role in the natural aging of cartilage, as well as the development and progression of OA.  (posted Oct. 8, 2013)

Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia

Lara C. Pullen, PhD  |  October 4, 2013

A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy.   (posted Oct. 3, 2013)

Immunology Research Pioneers Receive Carol Nachman Prize

Amanda Rillo  |  October 1, 2013

Rheumatologists Gerd R. Burmester, MD, of Berlin, and Michael B. Brenner, MD, of Boston, honored with prestigious international award

Interplay Between Physician Employment Agreements, Medical Staff Bylaws Should Not be Ignored

Steven M. Harris, Esq.  |  October 1, 2013

Doctors must consider and review bylaws of hospital medical staff privileges when entertaining employment with a hospital or private practice

EULAR 2013: New RA Recommendations Address Combination Therapy Concerns

Thomas R. Collins  |  October 1, 2013

Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment

My Experience at the ACR Dallas Rheumatology Research Workshop

Katarzyna Gilek-Seibert, MD  |  October 1, 2013

A second-year rheumatology fellow reflects on lectures and lessons learned at the event

Continued Congressional Lobbying by ACR Volunteers Needed to Repeal SGR

Staff  |  October 1, 2013

Ways you can advocate for legislation to replace the Medicare Sustainable Growth Rate formula

Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis

Staff  |  October 1, 2013

Disease Targeted Research Initiative may improve treatment, prevention of rheumatoid arthritis, other inflammatory diseases

New Insights into CPPD

Robert Terkeltaub, MD  |  October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

  • « Previous Page
  • 1
  • …
  • 235
  • 236
  • 237
  • 238
  • 239
  • …
  • 307
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences